海利生物：总经理韩本毅拟增持150万至200万元

Core Viewpoint - The company announced that its director and general manager, Han Benyi, plans to increase his stake in the company by purchasing shares in the A-share market between February 1, 2026, and July 31, 2026, with a total investment amounting to no less than 1.5 million RMB and no more than 2 million RMB, without setting a price range for the purchases [1] Group 1 - Han Benyi holds 1.98 million shares, representing 0.30% of the total share capital [1] - The planned share buyback will be conducted through centralized bidding [1] - The total investment for the share purchase is specified to be between 1.5 million RMB and 2 million RMB [1]